Treating physicians need information about the molecular subtype of the tumor if they are to provide targeted therapy for colorectal carcinoma. A research team from University Hospital Zurich and the ...
A multi-national team of clinicians and scientists have discovered a fundamental dichotomous grouping of colorectal cancer cells that proposes an update to the CMS classification system, that can ...
A phase II trial of salvage treatment with gemcitabine and S-1 combination in heavily pretreated patients with metastatic colorectal cancer. This is an ASCO Meeting Abstract from the 2012 ASCO Annual ...
The genetic confirmation of a suspected diagnosis of "hereditary colorectal cancer" is of great importance for the medical care of affected families. However, many of the variants identified in the ...
THE interesting library classification code set forth in this book by the Librarian of the University of Madras differs from others in that instead of showing a class subdivision for every topic, the ...
Analysis of RAS/BRAF mutations in a randomized phase II WJOG6510G study of panitumumab plus irinotecan versus cetuximab plus irinotecan in chemorefractory metastatic colorectal cancer. Association of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback